These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2512038)

  • 21. Treatment of acromegaly.
    Aloia JF; Field RA; Kramer S
    Arch Intern Med; 1973 Apr; 131(4):509-15. PubMed ID: 4633586
    [No Abstract]   [Full Text] [Related]  

  • 22. Controversy: radiotherapy for acromegaly.
    Thorner MO
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):136-7. PubMed ID: 12580926
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypopituitarism following pituitary irradiation for acromegaly.
    Aloia JF; Archambeau JO
    Horm Res; 1978; 9(4):201-7. PubMed ID: 669570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Indications and results of pituitary radiotherapy after microsurgery in acromegaly. 15 cases].
    Guittard M; Kuttenn F; Valcke JC; Mauvais-Jarvis P
    Presse Med; 1987 Jun; 16(25):1217-21. PubMed ID: 2955371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on pituitary irradiation using a proton beam with special reference to its indications in acromegaly by the Kjellberg stereotoxic hypophysectomy].
    Shintani A; Kjellberg RN
    No To Shinkei; 1969 Jan; 21(1):57-67. PubMed ID: 4888450
    [No Abstract]   [Full Text] [Related]  

  • 26. Growth hormone response to oral glucose before and after transfrontal pituitary surgery and radiotherapy in acromegaly.
    Dash RJ; Saini JS; Chander S; Kak VK; Ayyagari S
    J Assoc Physicians India; 1986 Mar; 34(3):171-3. PubMed ID: 3015867
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
    Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of radiotherapy for acromegaly on circulating prolactin.
    Ciccarelli E; Corsello SM; Plowman PN; Jones AE; Touzel R; Rees LH; Besser GM; Wass JA
    Acta Endocrinol (Copenh); 1989 Dec; 121(6):827-32. PubMed ID: 2609904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete remission of acromegaly with medical treatment.
    Spark RF; Dickstein G; Pallotta J
    JAMA; 1979 Feb; 241(6):573-5. PubMed ID: 762812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels.
    Lindsay JR; McConnell EM; Hunter SJ; McCance DR; Sheridan B; Atkinson AB
    Pituitary; 2004; 7(3):139-144. PubMed ID: 16328564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of 90Y pituitary implantation in acromegaly.
    Jadresic A; Jimenez LE; Joplin GF
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):301-6. PubMed ID: 3618081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotaxic pituitary implantation of yttrium-90 and iridium-192 for acromegaly.
    Jadresic A; Poblete M
    J Clin Endocrinol Metab; 1967 Oct; 27(10):1503-7. PubMed ID: 4862202
    [No Abstract]   [Full Text] [Related]  

  • 33. Sebum excretion in acromegaly.
    Burton JL; Libman LJ; Cunliffe WJ; Wilkinson R; Hall R; Shuster S
    Br Med J; 1972 Feb; 1(5797):406-8. PubMed ID: 4333483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent data on the results of treatments of acromegaly].
    Albeaux-Fernet M; Bellot L; Canet L; Deribreux J; Gelinet M
    Annee Endocrinol; 1970; 22():99-106. PubMed ID: 5485077
    [No Abstract]   [Full Text] [Related]  

  • 36. Conventional supervoltage irradiation is an effective treatment for acromegaly.
    Eastman RC; Gorden P; Roth J
    J Clin Endocrinol Metab; 1979 Jun; 48(6):931-40. PubMed ID: 447799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of acromegaly with special reference to trans-sphenoidal hypophysectomy.
    Williams RA; Jacobs HS; Kurtz AB; Millar JG; Oakley NW; Spathis GS; Sulway MJ; Nabano JD
    Q J Med; 1975 Jan; 44(173):79-98. PubMed ID: 1153691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion.
    Lamberg BA; Kivikangas V; Vartianen J; Raitta C; Pelkonen R
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):267-81. PubMed ID: 818860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of rise in serum prolactin following yttrium-90 interstitial irradiation for acromegaly.
    Clark AJ; Chahal P; Mashiter K; Joplin GF
    Clin Endocrinol (Oxf); 1983 Nov; 19(5):557-63. PubMed ID: 6416717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent or recurrent acromegaly. Long-term endocrinologic efficacy and neurologic safety of postsurgical radiation therapy.
    Goffman TE; Dewan R; Arakaki R; Gorden P; Oldfield EH; Glatstein E
    Cancer; 1992 Jan; 69(1):271-5. PubMed ID: 1727672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.